BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Home > article

Moon visits announces potential deal with Novavax for 20 mln people: Yonhap

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : January 20, 2021, 16:10 | Updated : January 20, 2021, 16:10
  • 트위터
  • 페이스북
  • 웨이보
 

[Yonhap News Photo]


SEOUL -- President Moon Jae-in visited a coronavirus vaccine production plant in South Korea and announced that the government could potentially secure additional new coronavirus vaccines for 20 million people from U.S. drug manufacturer Novavax Inc.

"The possibility has opened for us to secure additional vaccines for 20 million people, in addition to the already secured volume for 56 million, amid the pursuit of a deal between Novavax and SK Bioscience Co. recently," Moon said during the tour of SK's coronavirus vaccine production facility in Andong, North Gyeongsang Province, 270 kilometers southeast of Seoul.

Moon made the on-site inspection to encourage workers to produce high-quality and safe vaccines on the first anniversary of the COVID-19 outbreak in the country, according to Cheong Wa Dae. It came as the government was in full preparations to begin public inoculations for COVID-19 next month, beginning with medical workers.'

In addition to the already secured volume for 56 million people, Seoul has been eyeing the purchase of additional vaccines from Novavax through a potential deal between the U.S. company and SK. The initially reported volume under negotiation with Novavax was for 10 million people. Last year, SK inked a separate contract manufacturing agreement with Novavax, as well as AstraZeneca.

Moon said last week that the government will provide free COVID-19 vaccines to all South Koreans starting next month. "This deal (under negotiation between SK and Novavax) bears significance, as it not only entails consignment production but also the transfer of technology. It will play a big role in advancing the development of our country's (own proprietary) vaccine," Moon said.

Moon also held a teleconference with Novavax President and CEO Stanley Erck and discussed the company's vaccine production arrangement with SK Bioscience. He stressed the significance of South Korea's "vaccine sovereignty" as well.

"Our own vaccine development is very important in terms of allowing stable inoculation and establishing autonomy (in medical treatment) in case the coronavirus can't be eradicated in a short period of time," Moon said. In light of SK's consignment production deals with two major vaccine companies, Moon said the international community has pinned high hopes on South Korea's vaccine production capabilities. "Our companies' vaccine production capacity is world-class," Moon said.
(Yonhap)

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .SK Bioscience agrees to produce antigen of Novavax COVID-19 vaccine candidate.
    SK Bioscience agrees to produce antigen of Novavax COVID-19 …
  • .SK Bioscience embarks on clinical test of COVID-19 vaccine candidate NBP2001 .
    SK Bioscience embarks on clinical test of COVID-19 vaccine c…
  • .S. Korea unveils practical goal to vaccinate 70% of population.
    S. Korea unveils practical goal to vaccinate 70% of populati…

Real Time Photo News

  • .KT jumps into Vietnams music streaming market with digital platform.

    KT jumps into Vietnam's music streaming market with digital platform

  • .K-pop girl band MAMAMOOs label acquires rival entertainment company.

    K-pop girl band MAMAMOO's label acquires rival entertainment company

  • .BTS agency expands U.S. business scope thru acquisition of Ithaca Holdings.

    BTS agency expands U.S. business scope thru acquisition of Ithaca Holdings

  • .CJs drama-making wing forges partnership with webcomics studio YLAB.

    CJ's drama-making wing forges partnership with webcomics studio YLAB

  • .Historical inaccuracies lead to rare withdrawal of TV series in S. Korea.

    Historical inaccuracies lead to rare withdrawal of TV series in S. Korea

Latest News

more+

  • [FOCUS] President Moon hails rollout of home-made fighter jet as 'historic milestone'
  • Researchers develop tiny wearable metasurface gas sensor for holographic visual alarms
  • Researchers discover method to mass-produce carminic acid from glucose
  • KT jumps into Vietnam's music streaming market with digital platform
  • Daewoo shipyard gets smarter with advanced digital technologies
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view